Status:
ACTIVE_NOT_RECRUITING
Targeting Inflammation for Endometrial Cancer Prevention
Lead Sponsor:
Mayo Clinic
Conditions:
Endometrial Carcinoma
Eligibility:
FEMALE
18+ years
Brief Summary
This study examines risk assessment and identifies prevention strategies for endometrial cancer. Collecting samples of blood and urine and risk assessments from patients with benign conditions or endo...
Detailed Description
PRIMARY OBJECTIVE: I. To develop a model for a biobank that can be expanded across the Mayo Enterprise and implemented at extramural collaborative sites, including underserved populations. OUTLINE: ...
Eligibility Criteria
Inclusion
- Women over the age of 18 years old undergoing hysterectomy for any benign indication or endometrial cancer
Exclusion
- Men
- Women under the age of 18 years
- Women with a history of cancer, except for endometrial cancer or non-melanoma skin cancer
- Women with type 1 diabetes
- Women that have received radiation or chemotherapy for cancer
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2027
Estimated Enrollment :
191 Patients enrolled
Trial Details
Trial ID
NCT05407025
Start Date
December 1 2021
End Date
December 31 2027
Last Update
December 19 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259
2
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980